Effect of Diallyl Trisulfide on Ischemic Tissue Injury and Revascularization in a Diabetic Mouse Model

J Cardiovasc Pharmacol. 2018 Jun;71(6):367-374. doi: 10.1097/FJC.0000000000000579.

Abstract

Background and objective: Allitridin [diallyl trisulfide (DATS)] is an extract from garlic (Allium sativum) that putatively improves endothelial function and is protective against cardiovascular diseases. Endothelial dysfunction after tissue ischemia in diabetic patients is partially due to poor angiogenic response. This study investigated whether DATS may improve angiogenesis in a diabetic mouse model with hind limb ischemia.

Methods: Streptozotocin was administered by intraperitoneal injection to establish the model of diabetes in male C57BL/6 mice. After 14 days, nondiabetic and diabetic mice (n = 24, each) underwent unilateral hind limb ischemia by femoral artery ligation. The mice were apportioned to 4 groups: nondiabetic treated (or not) with DATS and diabetic treated (or not) with DATS. DATS treatment consisted of a single daily intraperitoneal injection of 500 μg·kg·d for 14 days, beginning on the day of induced ischemia. Ischemia was scored by standard criteria. Blood perfusion was determined using thermal infrared imaging. Tissue capillary density and oxidative stress levels were measured by immunohistochemistry and immunofluorescence, respectively. Serum lipids were measured by enzymatic colorimetric assay. Fasting serum insulin was detected using an insulin enzyme-linked immunosorbent assay kit. Nitric oxide (NO) metabolites and protein carbonyls in tissues were determined by enzyme-linked immunosorbent assay. Targeted protein concentrations were measured by western blotting.

Results: At 14 days after ligation, the ischemic skeletal muscle of the streptozotocin-induced diabetic mice had lower levels of endothelial NO synthase, phosphorylated endothelial NO synthase, and vascular endothelial growth factor compared with nondiabetic group. In addition, the hind limb blood perfusion, capillary density, and NO bioactivity were lower in the diabetic group, whereas oxidative stress and protein carbonyl levels were higher. These changes were ameliorated by DATS treatment.

Conclusions: DATS treatment of diabetic mice promoted revascularization in ischemic tissue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allyl Compounds / pharmacology*
  • Angiogenesis Inducing Agents / pharmacology*
  • Animals
  • Diabetes Mellitus, Experimental / complications*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / etiology
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / physiopathology
  • Hindlimb
  • Ischemia / drug therapy*
  • Ischemia / etiology
  • Ischemia / metabolism
  • Ischemia / physiopathology
  • Male
  • Mice, Inbred C57BL
  • Muscle, Skeletal / blood supply*
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Neovascularization, Physiologic / drug effects*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Oxidative Stress / drug effects
  • Phosphorylation
  • Protein Carbonylation / drug effects
  • Regional Blood Flow
  • Sulfides / pharmacology*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Allyl Compounds
  • Angiogenesis Inducing Agents
  • Sulfides
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
  • diallyl trisulfide
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Nos3 protein, mouse